M&T Bank Corp Baxter International Inc Transaction History

M&T Bank Corp

$29.1 Billion
Q2 2024

A detailed history of M&T Bank Corp transactions in Baxter International Inc stock. As of the latest transaction made, M&T Bank Corp holds 48,692 shares of BAX stock, worth $1.75 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

48,692

Previous 49,279 1.19%

Holding current value

$1.75 Million

Previous $2.11 Million 22.7%

% of portfolio

0.01%

Previous 0.01%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	SELL	$32.87 - $43.55 $19,294 - $25,563	-587 Reduced 1.19%	48,692 $1.63 Million
Q1 2024 May 07, 2024	SELL	$37.88 - $43.77 $2,272 - $2,626	-60 Reduced 0.12%	49,279 $2.11 Million
Q4 2023 Feb 06, 2024	SELL	$31.71 - $38.95 $190,608 - $234,128	-6,011 Reduced 10.86%	49,339 $1.91 Million
Q3 2023 Nov 02, 2023	SELL	$37.32 - $49.29 $120,692 - $159,403	-3,234 Reduced 5.52%	55,350 $2.09 Million
Q2 2023 Aug 09, 2023	BUY	$39.98 - $47.68 $35,382 - $42,196	885 Added 1.53%	58,584 $2.67 Million
Q1 2023 May 11, 2023	SELL	$37.58 - $52.57 $160,316 - $224,263	-4,266 Reduced 6.88%	57,699 $2.34 Million
Q4 2022 Feb 13, 2023	SELL	$49.7 - $57.71 $39,064 - $45,360	-786 Reduced 1.4%	55,228 $2.81 Million
Q4 2022 Feb 13, 2023	BUY	$49.7 - $57.71 $334,828 - $388,792	6,737 Added 12.2%	61,965 $3.16 Million
Q3 2022 Nov 14, 2022	SELL	$53.86 - $66.8 $13,141 - $16,299	-244 Reduced 0.43%	56,014 $3.02 Million
Q2 2022 Aug 05, 2022	BUY	$63.83 - $80.0 $121,404 - $152,160	1,902 Added 3.5%	56,258 $3.49 Million
Q1 2022 May 09, 2022	BUY	$76.85 - $89.45 $202,883 - $236,148	2,640 Added 5.1%	54,356 $4.22 Million
Q4 2021 Feb 07, 2022	SELL	$74.57 - $87.19 $137,581 - $160,865	-1,845 Reduced 3.44%	51,716 $4.44 Million
Q3 2021 Oct 28, 2021	SELL	$73.77 - $83.61 $130,720 - $148,156	-1,772 Reduced 3.2%	53,561 $4.31 Million
Q2 2021 Aug 13, 2021	BUY	$80.5 - $88.01 $17,227 - $18,834	214 Added 0.39%	55,333 $4.45 Million
Q1 2021 May 06, 2021	SELL	$76.38 - $86.03 $807,489 - $909,509	-10,572 Reduced 16.09%	55,119 $4.65 Million
Q4 2020 Feb 12, 2021	BUY	$75.39 - $82.36 $289,120 - $315,850	3,835 Added 6.2%	65,691 $5.27 Million
Q3 2020 Nov 06, 2020	SELL	$78.33 - $90.73 $120,314 - $139,361	-1,536 Reduced 2.42%	61,856 $4.97 Million
Q2 2020 Jul 29, 2020	SELL	$78.66 - $94.14 $364,353 - $436,056	-4,632 Reduced 6.81%	63,392 $5.46 Million
Q1 2020 May 14, 2020	BUY	$71.57 - $93.3 $391,416 - $510,257	5,469 Added 8.74%	68,024 $5.52 Million
Q4 2019 Feb 07, 2020	SELL	$76.7 - $88.45 $552,240 - $636,840	-7,200 Reduced 10.32%	62,555 $5.23 Million
Q3 2019 Nov 12, 2019	BUY	$81.4 - $89.78 $13,919 - $15,352	171 Added 0.25%	69,755 $6.1 Million
Q2 2019 Aug 12, 2019	SELL	$73.44 - $82.41 $600,886 - $674,278	-8,182 Reduced 10.52%	69,584 $5.7 Million
Q1 2019 May 15, 2019	SELL	$64.48 - $81.31 $784,915 - $989,786	-12,173 Reduced 13.53%	77,766 $6.33 Million
Q4 2018 Feb 01, 2019	SELL	$61.45 - $77.8 $504,381 - $638,582	-8,208 Reduced 8.36%	89,939 $5.92 Million
Q3 2018 Nov 09, 2018	SELL	$70.71 - $77.75 $1.52 Million - $1.67 Million	-21,466 Reduced 17.95%	98,147 $7.57 Million
Q2 2018 Aug 10, 2018	SELL	$63.43 - $75.41 $406,649 - $483,453	-6,411 Reduced 5.09%	119,613 $8.83 Million
Q1 2018 May 04, 2018	SELL	$62.56 - $72.26 $178,984 - $206,735	-2,861 Reduced 2.22%	126,024 $8.2 Million
Q4 2017 Feb 06, 2018	BUY	$61.45 - $66.05 $201,617 - $216,710	3,281 Added 2.61%	128,885 $8.33 Million
Q3 2017 Nov 13, 2017	SELL	$59.5 - $64.61 $283,279 - $307,608	-4,761 Reduced 3.65%	125,604 $7.88 Million
Q2 2017 Aug 11, 2017	BUY	N/A	130,365	130,365 $7.89 Million

Others Institutions Holding BAX

# of Institutions

996

Shares Held

449M

Call Options Held

1.97M

Put Options Held

3.04M

View Full List

About BAXTER INTERNATIONAL INC

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $18.2B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

More about BAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

News

Stay updated on M&T Bank Corp with notifications on news.

Account